Status:
NOT_YET_RECRUITING
Episodic Future Thinking to Improve Anticoagulant Adherence in Atrial Fibrillation
Lead Sponsor:
Jiawen You
Conditions:
Atrial Fibrillation (AF)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the effectiveness of Episodic Future Thinking (EFT) on improving medication adherence in atrial fibrillation (AF) patients taking oral anticoagulants. A total of...
Detailed Description
Participants (N = 68) will be randomly assigned to either an episodic future thinking (EFT) group or attention control group. We will use stratified block randomization. The randomization will be stra...
Eligibility Criteria
Inclusion
- Meets diagnostic criteria for atrial fibrillation per the Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation, with clinically stable condition
- Current or previous use of oral anticoagulants
- Age ≥18 years
- Capable of using WeChat mobile application
- Willing to provide informed consent
Exclusion
- Comorbid severe impairment of major organ systems or end-stage disease
- Significant visual or auditory impairments
- Documented cognitive dysfunction or psychiatric disorders (e.g., major depressive disorder, schizophrenia, bipolar disorder)
Key Trial Info
Start Date :
September 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2027
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT07174778
Start Date
September 15 2025
End Date
March 31 2027
Last Update
September 16 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Provincial People's Hospital
Guangzhou, Gangdong, China, 510080
2
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Gangdong, China, 510080